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Escherichia coli strains isolated from patients with different levels of urinary tract infection and from 
healthy persons were tested for their ability to haemagglutinate ndo-&galactosidase-treated human 
erythrocytes. Among the 104 strains studied one revealed a strong agglutination reaction with the enzyme- 
treated erythrocytes. From the monosaccharides tested N-acetyl-D-glucosamine inhibited agglutination 
most effectively. Orosomucoid and ciao-oro~mu~id had no effect on the haema~lutination whereas 
,&galactosidase treated asialo-orosomucoid was inhibitory. These findings indicate that the E. coii strain 
studied contains a novel cell-binding activity with specificity for terminal N-acetyl-D-glucosamine residues. 
N-Acetyl-D-glucosamine Bacterial adhesion 
Haemagglutination 
1. INTRODUCTION 
Bacterial adhesion to host epithelium is an im- 
portant virulence factor in many infectious 
diseases [11, and has probably also a role in the 
stabilization of the normal bacterial flora; e.g., in 
the mouth and intestine [2,3]. It is evident that this 
adhesion is receptor-mediated, although only a few 
receptors are known at the molecular level. Most 
~sc~er~c~j~ coli strains, regardless of their origin, 
are able to bind to a-D-mannosyl residues on 
epithelial cells and erythrocytes by their type I fim- 
briae [4-6). Most E. coli strains associated with 
human pyelonephritis carry P fimbriae, which 
recognize blood-group P determinants on human 
erythrocytes and urinary tract epithelial cells 
[7-g]. Two other receptor structures for E. co& are 
also known: blood-group M determinants [IO] and 
sialyl (cY2-3)galactosides [Ill. The molecular 
nature of the bacterial adhesins binding to the lat- 
ter two structures has not yet been resolved. We 
now describe a novel binding specificity in a strain 
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of E. coli. This interaction is based on the bacterial 
binding to N-acetyl-D-glucosamine residues that 
become exposed after treating erythrocytes with 
endo-@-galactosidase. 
2. MATERIALS AND METHODS 
2.1. Bacteria 
Three E. coli strains showing marmose-resistant 
blood-group M-specific haemagglutination were 
studied: IH 11165 (serotype 02) was isolated from 
a patient with acute pyelonephritis [IO], IH 3082 
(08H19) from a patient with newborn meningitis, 
and KS 300 was kindly donated by Dr G. Kglllenius 
(National Bacteriological Laboratory, Stockholm) 
and was not typable with the antisera available [9]. 
In addition, 63 strains lacking D-mannose-resis- 
tant haemagglutination activity of human OPI or 
Op erythrocytes, and 38 strains showing only P- 
specific agglutination, were tested. These strains 
had been isolated from the urine of patients with 
different levels of urinary tract infection (85 
strains) or from faeces of healthy children (16 
strains). The strains and their serotyping have been 
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described [9]; (submitted). The strains lacking D- 
mannose-resistant haemagglutination were of O- 
serotypes: 1 (four strains), 2 (three strains), 4 (two 
strains), 6 (twelve strains), 7 (one strain), 8 (five 
strains), 9 (two strains), 18 (five strains), 22 (seven 
strains), 25 (six strains), 50 (three strains), 75 
(seven strains), 77 (five strains) or 85 (one strain). 
The P-fimbriated strains were of 0-serotypes: 1 
(seven strains), 2 (seven strains), 4 (nine strains), 6 
(five strains), 18 (four strains), 22 (one strain), 75 
(one strain) or 16 (three strains). One of the P- 
fimbriated strains was not typable with the sera 
available. For haemagglutination tests the bacteria 
were grown on CFA-agar plates as in [9]. 
2.2. Endo-~-ga~actosid~e treatment 
Washed human erythrocytes (250~1) were sus- 
pended in 650 ~1 10 mM sodium phosphate (pH 
7.4) containing 0.15 M NaCl, and 10 mU Escher- 
ichia freundii endo-&galactosidase (Seikagaku 
Kogyo, Tokyo) was added in 100 pl 50 mM 
sodium acetate buffer (pH 5.8). The erythrocytes 
were incubated at 37’C for 2 h with occasional 
mixing and washed by repeated centrifugations. 
The appearance of terminal N-acetylglu- 
cosamine residues on the erythrocytes was 
mo~tored by incubations with g~actosyltr~s- 
ferase and UDP-D-[r4C]galactose, which indicated 
the presence, of 2.5 x lo6 acceptor sites/cell in the 
treated erythrocytes as opposed to 0.05 x lo6 
sites/cell in untreated erythrocytes (in 
preparation). 
2.3. Haemagglutination tests 
Haemagglutinations were performed on glass 
slides at room temperature as in [6,9,1 I]. All 
haemagglutinations were done in the presence of 
5% (w/v) methyl a-D-marmoside to study only 
D-mannose-r~ist~t a~lutination. For haemag- 
glutination inhibition studies the suspensions of 
E. coli IH 11165 (about 10” bacteria/ml 10 mM 
sodium phosphate buffer (pH 7.1), 0.15 M NaCl) 
were titrated in 2-fold dilutions with the 
erythrocytes, and a bacterial concentration cor- 
resending to twice the lowest haemagglutinating 
concentration was used. 
2.4. Inhibitors 
All monosaccharides and glycoproteins used 
were dissolved in 10 mM sodium phosphate con- 
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taining 0.15 M NaCl and adjusted to pH 7.1. 
Orosomucoid was kindly supplied by Dr G. 
Myllyla (Finnish Red Cross Blood Transfusion 
Service, Helsinki) and desialylated by treatment 
with 0.1 M HCl at 80°C for 1 h followed by 
dialysis against 50 mM NaCl; 20 mg desialylated 
orosomucoid was incubated in 2 ml 25 mM 
sodium citrate buffer (pH 3.8) containing 10~1 
toluene and 5 U purified Aspergiiflus niger @- 
galactosidase (kindly supplied by Dr J. Knowles, 
Biotechnical Laboratory, Technical Research 
Center of Finland) at 37°C for 3 days, after which 
5 U enzyme was added and the incubation con- 
tinued for 2 days during which time no more D- 
galactose was released. Gas-liquid chromato- 
graphic analysis [12] of the dialysed sample in- 
dicated that 55% of D-galactose residues had been 
removed. 
3. RESULTS AND DISCUSSION 
To prevent haemagglutination reactions due to 
the D-mannoside-binding activity commonly pre- 
sent in different strains of E. coii 14-61, all ag- 
glutination studies were performed in the presence 
of methyl tu-D-mannoside. For the detection of 
binding activities which under these conditions do 
not induce haemagglutination, we investigated 
whether erythrocytes could be modified by endo-@- 
galactosidase to render them agglutinable. 
It is known that human erythrocytes contain 
only small mounts of terminal N-acetyl-D- 
glucosamine residues ([I 31, in preparation). On the 
other hand, endo-fl-galactosidase is known to 
specifically cleave the polyglycosyl chains [ 141 pre- 
sent in the erythrocyte membrane glycoproteins 
and glycolipids so that tennina N-acetyl-D- 
glucosamine residues become exposed [ 15,161. We 
therefore tested 65 non-haemagglutinating strains 
of E. coli using endo-,&galactosidase treated Pi 
erythrocytes to reveal N-acetyl-D-glucosamine 
recognition. In addition 38 strains known to con- 
tain blood-group P-specific adhesion activity [7-9] 
were tested with endow-galactosid~e treated p 
erythrocytes and 3 strains known to contain blood- 
group M-binding specificity [lo] were tested with 
enzyme-treated NN erythrocytes to avoid haemag- 
glutinations due to these binding specificities. 
From the 104 E. co/i strains studied, one (IH 
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11165) revealed a strong agglutination reaction 
with endo-&galactosidase treated erythrocytes 
(table 1). This strain has previously been shown to 
contain a binding activity with specificity for 
blood-group M erythrocytes [101. These two speci- 
ficities seem, however, to be clearly distinguish- 
able, since the two other strains containing the M- 
specific activity did not agglutinate nzyme-treated 
N erythrocytes (table 1). Endo&galactosidase 
treatment had only a slight effect on the agglutina- 
tion of M erythrocytes by these strains. Expected- 
ly, there was a slight increase in the titer of strain 
IH 11165, as opposed to a slight decrease in the 
titer of the two other strains. 
To study whether the haemagglutination of the 
endo-,&galactosidase treated erythrocytes by strain 
IH 11165 was in fact due to recognition of N- 
acetyl-D-glucosamine residues, different monosac- 
charides were tested for haemagglutination i hibi- 
tion. N-Acetyl-D-glucosamine inhibited the hae- 
magglutination at 2.1 mM, D-glucose and D- 
mannose were much less effective, and N-acetyl-D- 
galactosamine, L-galactose and L-fucose were in- 
effective at the concentrations tudied. 
In accordance with the haemagglutination in- 
hibition studies with the monosaccharides, the 
glycoprotein orosomucoid and its desialylated 
derivative did not cause haemagglutination i hibi- 
tion at the concentrations studied (1.9 mg/ml, 
table 1). However, P-galactosidase-treated oroso- 
mucoid inhibited haemagglutination at about 0.5 
mg/ml, which corresponds to about 0.13 mM with 
respect to terminal N-acetyl-D-glucosamine 
residues. The concentrations of monosaccharide 
and macromolecular inhibitors were thus of the 
same orders of magnitude as those required to in- 
Table 1 
Agglutination titers of E. coli strains with control and 
endo-fl-galactosidase-treated rythrocytes 
Erythrocytes E. coli strain 
IH IH KS 
11165 3082 300 
MM 256 512 256 
MM + endo-&galactosidase 512 64 128 
NN 0 0 0 
NN + endo-&galactosidase 64 0 0 
Table 2 
Inhibition of haemagglutination of endo-fl-galactosid- 
ase-treated erythrocytes by E. coli IH 11165 
Inhibitor MIC= 
N-Acetyl-D-glucosamine 2.1 mM 
D-Glucose 32 mM 
D-Mannose 130 mM 
L-Fucose >130 mMb 
D-Galactose >130 mMb 
N-Acetyl-D-galactosamine ~130 mMb 
Orosomucoid > 1.9 mg/ml 
Asialo-orosomucoid > 1.9 mg/ml 
Agalactosyl-orosomucoid 0.48 mg/ml 
* Minimal inhibitory concentration required to prevent 
haemagglutination 
b Not inhibitory at 130 mM 
hibit D-mannoside or neuraminyl(a2-3)galacto- 
side recognition [11,17]. 
From the E. coli strains studied those classified 
as non-haemagglutinating were faecal isolates 
from healthy persons and urinary isolates from pa- 
tients with different levels of urinary tract infec- 
tion. The P-fimbriated strains were mostly pyel- 
onephritogenic and represented all the common 
serotypes of E. coli strains associated with human 
pyelonephritis. Thus, although strain IH 11165 
was isolated from a l-year-old girl with acute 
pyelonephritis [9,10], it seems that the novel bin- 
ding specificity is rare at least among human pye- 
lonephritogenic strains. 
The molecular nature of the bacterial haemag- 
glutinin with specificity for N-acetyl-D-glucos- 
amine is so far unresolved. We have found that the 
purified E. coli IH 11165 fimbriae show a strong 
M-specific haemagglutination but lack the N- 
acetyl-D-glucosamine binding activity (unpublish- 
ed). It may be that N-acetyl-D-glucosamine 
recognition resides in a non-fimbrial haemag- 
glutinin which has been proposed to exist in some 
E. coli [ 181. Such haemagglutinins have not been 
purified and their molecular nature is so far 
unknown. 
An important aspect of the findings here is also 
that the binding property of a bacterial strain can 
only be observed after modification of the erythro- 
cyte surface; e.g., by the endo-fl-galactosidase used 
here. It is known that some fimbriae, such as the 
235 
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987P fimbriae of porcine enterotoxigenic E. coli 
[ 191, have no demonstrable haemagglutination ac- 
tivities, although they mediate adhesion to epithe- 
lial cells. A likely explanation is that the ap- 
propriate receptor structures are lacking on the 
erythrocyte surface. Use of specific enzymes, such 
as glycosidases and glycosyltransferases, to modify 
the erythrocyte surface structures could be a useful 
tool in the identification and characterization of 
microbial receptors. 
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